Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Novo Nordisk A/S gives FY 2014 guidance


Thursday, 1 May 2014 02:00am EDT 

Novo Nordisk A/S:Sees FY 2014, sales growth measured in local currencies is now expected to be 7 pct. - 10pct.FY 2014 operating profit growth in local currencies is maintained at around 10 pct. 

Company Quote

48.1
0.48 +1.01%
1 Oct 2014